Novoheart Holdings announced its financial results for the first quarter of 2018.
Novoheart Holdings (TSXV:NVH) announced its financial results for the first quarter of 2018.
As quoted in the press release:
“This first quarter as a public company was very much about ensuring the long-term viability of Novoheart well into the future and I adamantly believe we accomplished this through several channels,” said Dr. Ronald Li, CEO of Novoheart. “The initial capital secured in the first quarter has allowed us to establish locations in both North America and Hong Kong, two locations that are critical for us to be active in. Furthermore, we have actively invested in infrastructure that will allow us to be at the forefront of innovation and further advance our commercial scalability in the near future.”
Q1 2018 Highlights:
- Completed listing on the TSX Venture Exchange by way of a reverse takeover and a concurrent financing of C$7.15 million
- New R&D location at The Cove in Irvine, California
- Expansion of lab and office facilities at Hong Kong Science Park